Diagnostic genomic sequencing in critically ill children.

Area of Science:

• Pediatric critical care medicine
• Genomic medicine
• Rare disease diagnostics

Background:

• Rare genetic diseases cause significant infant mortality and morbidity.
• Clinical diagnosis of monogenetic diseases in critically ill children is challenging due to atypical presentations.
• Early molecular diagnosis is crucial for effective clinical management.

Purpose of the Study:

• To review the current applications of rapid genomic sequencing in critically ill children.
• To highlight the diagnostic and clinical value of expedited genomic testing.
• To discuss the future potential of rapid genomic sequencing in pediatric care.

Main Methods:

• Review of existing literature on rapid exome and genome sequencing in critically ill pediatric populations.
• Analysis of studies demonstrating the impact of timely molecular diagnoses on patient outcomes.
• Exploration of the integration of genomic sequencing into clinical workflows.

Main Results:

• Rapid genomic sequencing offers significant diagnostic yield in critically ill children.
• Faster molecular diagnoses correlate with improved clinical management and patient outcomes.
• Precision medicine approaches guided by genomic data can be implemented earlier.

Conclusions:

• Rapid genomic sequencing is a powerful tool for diagnosing rare genetic diseases in critically ill infants and children.
• Timely molecular diagnosis facilitates personalized treatment strategies, improving patient outcomes.
• Genomic sequencing integration promises enhanced healthcare efficiency and cost savings.